ConductScience.org, home

Paper30153293

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Li H and 19 others. PLoS One, 2018. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. Papers, record 30153293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30153293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
PubMed
Journal
PLoS One
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2019-02-15
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li HHongzhao
2Hai YYan
3Lim SYSo-Yon
4Toledo NNikki
5Crecente-Campo JJose
6Schalk DDane
7Li LLin
8Omange RWRobert W
9Dacoba TGTamara G
10Liu LRLewis R
11Kashem MAMohammad Abul
12Wan YYanmin
13Liang BBinhua
14Li QQingsheng
15Rakasz EEva
16Schultz-Darken NNancyhttps://orcid.org/0000-0002-8436-2820
17Alonso MJMaria J
18Plummer FAFrancis A
19Whitney JBJames B
20Luo MMahttps://orcid.org/0000-0002-9827-4071

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Products, envMajor topic
Gene Products, gagMajor topic
Peptide HydrolasesMajor topic
ProteolysisMajor topic
SAIDS VaccinesMajor topic
Simian Immunodeficiency VirusMajor topic
Amino Acid Sequence
Animals
Antibodies, Viral
Binding Sites
Cross Reactions
Female
Immunization
Macaca fascicularis

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
C06 RR015459NCRR NIH HHSUnited StatesC06RR015459PubMed and NIHNIH RePORTER
C06 RR020141NCRR NIH HHSUnited StatesC06RR020141PubMed and NIHNIH RePORTER
P51 OD011106NIH HHSUnited StatesP51OD011106PubMed and NIHNIH RePORTER
R01 AI111805NIAID NIH HHSUnited StatesR01AI111805PubMed and NIHNIH RePORTER
Canadian Institutes of Health ResearchInternationalPubMedPubMed

Download CSV of grants

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19358557Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines.Pharm Res1997https://conductscience.org/library/papers/9358557PubMed
228748659Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.J Med Primatol2017https://conductscience.org/library/papers/28748659PubMed
323614052A polymer/oil based nanovaccine as a single-dose immunization approach.PLoS One2013https://conductscience.org/library/papers/23614052PubMed
417898737HIV vaccine failure prompts Merck to halt trial.Nature2007https://conductscience.org/library/papers/17898737PubMed
525591175Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.Virology2015https://conductscience.org/library/papers/25591175PubMed
623664989Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites.Vaccine2013https://conductscience.org/library/papers/23664989PubMed
728725225Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Front Immunol2017https://conductscience.org/library/papers/28725225PubMed
828422786Antibody-mediated immune exclusion of HIV.Curr Opin HIV AIDS2017https://conductscience.org/library/papers/28422786PubMed
912915557Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?J Virol2003https://conductscience.org/library/papers/12915557PubMed
1020634666Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype.AIDS2010https://conductscience.org/library/papers/20634666PubMed
1119534569Virus maturation as a new HIV-1 therapeutic target.Expert Opin Ther Targets2009https://conductscience.org/library/papers/19534569PubMed
1223364441Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.AIDS2013https://conductscience.org/library/papers/23364441PubMed
1322072744For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.J Virol2012https://conductscience.org/library/papers/22072744PubMed
1428893268A novel HIV vaccine targeting the protease cleavage sites.AIDS Res Ther2017https://conductscience.org/library/papers/28893268PubMed
1528893288Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design.AIDS Res Ther2017https://conductscience.org/library/papers/28893288PubMed
168510215Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.J Virol1993https://conductscience.org/library/papers/8510215PubMed
1711739694ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.J Virol2002https://conductscience.org/library/papers/11739694PubMed
1824813074HIV vaccines: a brief overview.Scand J Immunol2014https://conductscience.org/library/papers/24813074PubMed
1925009956Recent progress in HIV vaccines inducing mucosal immune responses.AIDS2014https://conductscience.org/library/papers/25009956PubMed
209680484The role of structure in antibody cross-reactivity between peptides and folded proteins.J Mol Biol1998https://conductscience.org/library/papers/9680484PubMed

See all 76 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41902278Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques.Viruses2026https://conductscience.org/library/papers/41902278PubMed
38979723A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity.Emerg Microbes Infect2024https://conductscience.org/library/papers/38979723PubMed
37337294Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods.Virol J2023https://conductscience.org/library/papers/37337294PubMed
35592073Toll-like Interleukin -1 Receptor Regulator (TILRR) Protein, a Major Modulator of Inflammation, is Expressed in Normal Human and Macaque Tissues and PBMCs.J Inflamm Res2022https://conductscience.org/library/papers/35592073PubMed
32983121Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens.Front Immunol2020https://conductscience.org/library/papers/32983121PubMed
32853182Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.J Clin Invest2020https://conductscience.org/library/papers/32853182PubMed
31523362Antiretroviral drug-S for a possible HIV elimination.Int J Physiol Pathophysiol Pharmacol2019https://conductscience.org/library/papers/31523362PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
INHCAP100129696PubTator's text mininghttps://conductscience.org/library/genes/100129696NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30153293

GET https://conductscience.org/api/papers/v1/30153293/references?page=2